Kathmandu, Nepal – Arrow Pharmaceuticals Pvt. Ltd., a rapidly growing pharmaceutical manufacturing and marketing company, successfully concluded its first Annual General Meeting (AGM) at Hotel Pauwa, Kathmandu. Founded by three experienced professionals with expertise in senior management roles, the company has quickly positioned itself as a key player in Nepal’s pharmaceutical industry, driven by its mission to deliver high-quality medicines at affordable prices.
Addressing the AGM, Managing Director Dr. Pankaj K. Tiwari emphasized the company’s commitment to quality, innovation, and ethical practices. "Arrow is a group of creative, experienced, and dedicated professionals who go beyond conventional practices to ensure the delivery of high-quality medicines and services. With the support of our prescribers and stakeholders, Arrow aims to create substantial employment opportunities for Nepalese citizens—a true need of our motherland," he stated.
The company’s manufacturing facility in Bhaktapur is designed to meet international standards, featuring two separate blocks. Block A is dedicated to general medicines, while Block B is reserved for the production of Cephalosporin antibiotics. Spanning a built-up area of 51,000 square feet, the plant is equipped with state-of-the-art technology and operates under the Clean Room Concept, adhering to Current Good Manufacturing Practices (cGMP).
Arrow Pharmaceuticals’ sales team also plays a pivotal role, promoting ethical practices and building trust among prescribers. This unified approach has allowed the company to rapidly establish itself in Nepal’s competitive pharmaceutical market.
With its focus on innovation, sustainability, and social responsibility, Arrow Pharmaceuticals is not only advancing healthcare in Nepal but also creating valuable job opportunities for the nation’s citizens. As the company concludes its first AGM, it sets a promising trajectory for growth, aiming to bridge the gap between affordability and quality in the healthcare sector.
Ecosphere News will continue to follow Arrow Pharmaceuticals’ journey and its impact on Nepal's pharmaceutical landscape.